Russia’s focus on domestic pharma production could shield it from sanctions’ effects
Pharmaceutical Technology
JULY 4, 2022
Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. AbbVie (North Chicago, Illinois) and Novartis (Basel, Switzerland) have also withdrawn from their businesses in Russia.
305 
Let's personalize your content